Lotus Eye Hospital and Institute has informed that pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, the Board of Directors of the company will be meeting on Tuesday, August 09,2022 to consider Unaudited Standalone Financial Results of the company for the quarter and year ended June 30, 2022. Further, with reference to earlier intimation June 30 2022, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from August 12, 2022 onwards.
The above information is a part of company’s filings submitted to BSE.
